OMNICELL, INC. OMCL

Technology SIC 3571 - Electronic Computers NAICS Manufacturing › Computer and Electronic Product Manufacturing › Computer and Peripheral Equipment Manufacturing › Electronic Computer Manufacturing derived Nasdaq

Omnicell, a leading healthcare technology provider focused on empowering autonomous medication management, is committed to solving the critical challenges inherent in medication management and elevating the role of clinicians within healthcare as an essential component of care delivery. Omnicell is focused on helping its customers define and deliver a cost-effective medication management strategy designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. We are doing this with an industry-leading medication management infrastructure which includes storage and dispensing automation powered by an intelligence ecosystem. Our comprehensive set of solutions provides the critical foundation for customers to realize the Autonomous Pharmacy, an industry-wide vision defined by pharmacy leaders for improving operational efficiencies and ultimately targeting zero-error medication management alongside 5 other outcomes laid out in the Autonomous Pharmacy framework.

Last close 37.75 2026-10-23
Market cap $1.72B 2026-06-30 share count
52-week range 29.09 - 55.00

Valuation FY2025 figures against the last close

P/S1.5x
P/E943.8x
P/FCF19.8x
EV/EBITDA20.5x
Dividend yield—
Diluted EPS0.04

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • United States
  • Rest of world
Revenue by geography, 2 categories over 3 years. The same figures are in the table below. FY2025 United States, FY2025: 1.1B (89.9%) 90% United States Rest of world, FY2025: 119.8M (10.1%) 10% Rest of world FY2024 United States, FY2024: 1B (91.0%) 91% Rest of world, FY2024: 99.9M (9.0%) 9% FY2023 United States, FY2023: 1B (88.2%) 88% Rest of world, FY2023: 135.7M (11.8%) 12%
Region FY2025FY2024FY2023
United States $1.07B $1.01B $1.01B
Rest of world $119.8M $99.9M $135.7M

As the company reported it, from the “Revenues - Schedule of Disaggregation of Revenues by Geographic Region (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $1.18B$1.11B$1.15B$1.30B$1.13B$892.2M$897.0M$787.3M$712.7M$695.9M
Cost of revenue $681.4M$641.2M$650.3M$707.0M$577.4M$478.9M$460.1M$415.0M$394.1M$378.8M
Gross profit $503.4M$471.0M$496.8M$589.0M$554.7M$413.3M$436.9M$372.3M$318.6M$317.1M
R&D $88.7M$90.4M$97.1M$105.0M$75.7M$70.2M$68.6M$64.8M$66.0M$57.8M
SG&A $409.6M$380.3M$434.6M$486.3M$389.4M$307.6M$289.9M$263.1M$241.5M$237.9M
Total operating expenses $498.3M$470.7M$531.7M$591.3M$465.1M$377.8M$358.6M$327.9M$307.5M$295.7M
Operating income $5.2M$337.0K-$34.9M-$2.3M$89.5M$35.5M$78.4M$44.4M$11.1M$21.4M
Pre-tax income $11.3M$25.6M-$20.1M-$2.5M$66.0M$29.3M$73.9M$35.6M$4.5M$13.0M
Income tax $9.3M$13.1M$263.0K$8.1M$11.8M$2.8M$12.6M$2.1M$26.0M$3.2M
Net income $2.1M$12.5M-$20.4M$5.6M$77.8M$32.2M$61.3M$37.7M$30.5M$9.8M
EPS, basic 0.040.27-0.450.131.790.761.480.960.810.27
EPS, diluted 0.040.27-0.450.121.620.741.430.930.790.26
Shares, diluted (wtd. avg.) 46.4M46.3M45.2M45.9M47.9M43.7M42.9M40.6M38.7M36.9M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $196.5M$369.2M$468.0M$352.8M$355.6M$489.9M$127.2M$67.2M$32.4M$54.5M
Receivables $216.9M$256.4M$252.0M$299.5M$240.9M$190.1M$218.4M$196.2M$190.0M$150.3M
Inventory $100.9M$88.7M$110.1M$147.5M$119.9M$96.3M$108.0M$100.9M$96.1M$69.3M
Total current assets $680.1M$815.5M$927.6M$881.8M$780.7M$829.4M$483.2M$397.1M$352.3M$315.4M
Property, plant and equipment $120.1M$112.7M$108.6M$94.0M$71.1M$59.1M$54.2M$51.5M$42.6M$42.0M
Goodwill $737.9M$734.7M$735.8M$734.3M$738.9M$499.3M$336.5M$335.9M$337.8M$327.7M
Other intangibles $170.1M$188.3M$211.2M$242.9M$277.6M$168.2M$124.9M$143.7M$168.1M$190.3M
Total assets $1.97B$2.12B$2.23B$2.21B$2.14B$1.82B$1.24B$1.08B$1.02B$935.1M
Accounts payable $44.0M$51.8M$45.0M$63.4M$71.5M$40.3M$46.4M$38.0M$48.3M$27.1M
Short-term debt ———————$0$15.2M$8.4M
Total current liabilities $476.6M$595.7M$367.8M$428.4M$876.2M$276.4M$237.0M$204.6M$205.2M$180.9M
Long-term debt ——————$50.0M$135.4M$194.9M$245.7M
Total liabilities $742.9M$877.6M$1.04B$1.08B$995.8M$857.0M$395.6M$401.6M$462.0M$503.5M
Retained earnings $384.9M$382.9M$370.4M$390.7M$368.6M$290.7M$258.8M$197.5M$159.7M$100.4M
Total equity $1.23B$1.24B$1.19B$1.13B$1.15B$967.5M$845.3M$679.6M$554.3M$458.8M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $127.3M$187.7M$181.1M$77.8M$231.8M$185.9M$145.0M$104.0M$24.8M$49.9M
Depreciation and amortisation $78.8M$82.2M$87.3M$86.9M$73.0M$61.1M$53.6M$51.4M$51.5M$58.4M
Stock-based compensation $44.5M$39.3M$55.3M$68.2M$53.2M$44.7M$34.0M$28.9M$21.9M$19.5M
Capital expenditure $40.4M$36.5M$41.5M$47.5M$29.0M$22.8M$15.9M$23.7M$15.3M$13.4M
Investing cash flow -$60.4M-$52.8M-$55.0M-$58.7M-$412.5M-$279.9M-$61.7M-$54.4M-$35.0M-$341.3M
Financing cash flow -$218.3M-$235.6M$23.4M-$21.0M$47.4M$456.3M-$23.5M-$13.6M-$9.9M$263.8M
Buybacks $77.6M$0$0$52.2M$0$53.0M$0$0$0$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-042631.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -500M 0 500M 1B 1.5B Revenue, FY2016: 695.9M Gross profit, FY2016: 317.1M Net income, FY2016: 9.8M Revenue, FY2017: 712.7M Gross profit, FY2017: 318.6M Net income, FY2017: 30.5M Revenue, FY2018: 787.3M Gross profit, FY2018: 372.3M Net income, FY2018: 37.7M Revenue, FY2019: 897M Gross profit, FY2019: 436.9M Net income, FY2019: 61.3M Revenue, FY2020: 892.2M Gross profit, FY2020: 413.3M Net income, FY2020: 32.2M Revenue, FY2021: 1.1B Gross profit, FY2021: 554.7M Net income, FY2021: 77.8M Revenue, FY2022: 1.3B Gross profit, FY2022: 589M Net income, FY2022: 5.6M Revenue, FY2023: 1.1B Gross profit, FY2023: 496.8M Net income, FY2023: -20.4M Revenue, FY2024: 1.1B Gross profit, FY2024: 471M Net income, FY2024: 12.5M Revenue, FY2025: 1.2B Gross profit, FY2025: 503.4M Net income, FY2025: 2.1M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $695.9M $712.7M $787.3M $897.0M $892.2M $1.13B $1.30B $1.15B $1.11B $1.18B
Gross profit $317.1M $318.6M $372.3M $436.9M $413.3M $554.7M $589.0M $496.8M $471.0M $503.4M
Net income $9.8M $30.5M $37.7M $61.3M $32.2M $77.8M $5.6M -$20.4M $12.5M $2.1M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Officer or director change Item 5.02
  • Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Results announced Item 2.02
  • Charter or fiscal year changed Item 5.03
  • Officer or director change Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 3571

TickerCompanyMarket capP/ERevenue growth
AAPL Apple Inc. $5.07T 46.6x 6.4%
DELL Dell Technologies Inc. $296.23B 52.6x 18.8%
SMCI Super Micro Computer, Inc. $21.64B 10.1x 77.8%
OSS ONE STOP SYSTEMS, INC. $147.4M 26.9x 31.2%
SCKT SOCKET MOBILE, INC. $4.2M — -19.6%
ZEPP Zepp Health Corp — — 41.8%
XNDU Xanadu Quantum Technologies Ltd — — —